The milk analysis company Miris has received an order for Miris HMA from the neonatal department at Östersunds sjukhus. The investment entails an upgrade of equipment for the analysis of human milk and confirms the clinical value of the company's technology. The order is worth SEK 366,000 and will be delivered in March."That Östersunds sjukhus chooses to reinvest in Miris HMA is a clear sign of the important role human milk analysis plays in Swedish neonatal care. That the reinvestment is also taking place within the timeframe we expected in our installed customer base strengthens the reliability of our sales forecasts," says Marie Ekholm, Head of Sales and Marketing at Miris.